Get notified when OFIX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: OFIX Orthofix Medical Inc. 8-K

Orthofix wins Medicare reimbursement restoration for bone growth stimulators

Filed July 2, 2026 · Period ending July 1, 2026 · ~1 min read

Key Changes

  • high

    CMS reversed May 18 billing changes for bone growth stimulators, restoring prior Medicare payment rates effective retroactively to May 18, 2026.

  • high

    Company expects average Medicare reimbursement to return to pre-May 18 levels, ending approximately six weeks under CMS's modified billing treatment.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (NKLR 10-Q) is open in full — no account needed.

Partner

Trade OFIX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 5, 2026 · How we verify